meglumine has been researched along with Weight Loss in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bliddal, H; Boesen, M; Gudbergsen, H; Hangaard, S; Nybing, JD; Skougaard, M; Tiderius, CJ | 1 |
| Daher, EF; Fonseca, PP; Gerhard, ES; Leitão, TM; Silva Júnior, GB | 1 |
| Blommaert, AG; Ducos, B; Fournie-Zaluski, MC; Maldonado, R; Roques, BP; Valverde, O | 1 |
| Gilead, L; Horev, L; Jonas, F; Klaus, SN; Zlotogorski, A | 1 |
| Ahmad, S; Rahim, F; Rehman, F; Zada, B | 1 |
| Boucher, M; Coudoré-Civiale, MA; Eschalier, A; Fournié-Zaluski, MC; Méen, M; Roques, BP | 1 |
6 other study(ies) available for meglumine and Weight Loss
| Article | Year |
|---|---|
Point of no return for improvement of cartilage quality indicated by dGEMRIC before and after weight loss in patients with knee osteoarthritis: a cohort study.
Topics: Aged; Cartilage, Articular; Cohort Studies; Contrast Media; Female; Follow-Up Studies; Humans; Image Enhancement; Knee Joint; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Obesity; Organometallic Compounds; Osteoarthritis, Knee; Weight Loss | 2018 |
Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Asthenia; Bone Marrow; Brazil; CD4 Lymphocyte Count; Cough; Diarrhea; Female; Fever; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Splenomegaly; Time Factors; Weight Loss | 2009 |
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308.
Topics: Analgesics; Animals; Behavior, Animal; Binding, Competitive; Body Temperature; Diprenorphine; Disulfides; Drug Combinations; Drug Synergism; Enkephalins; Indoles; Male; Meglumine; Mice; Morphine; Motor Activity; Naloxone; Phenylalanine; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Substance Withdrawal Syndrome; Weight Loss | 1995 |
South American cutaneous leishmaniasis: report of ten cases in Israeli travelers.
Topics: Adult; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Headache; Humans; Israel; Leg Ulcer; Leishmania mexicana; Leishmaniasis, Cutaneous; Liver; Liver Function Tests; Male; Meglumine; Meglumine Antimoniate; Muscle Weakness; Muscular Diseases; Organometallic Compounds; Pain; Retrospective Studies; Skin; South America; Travel; Weight Loss | 1998 |
Visceral leishmaniasis in District Dir, NWFP.
Topics: Abdomen; Anemia; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Fever; Hepatomegaly; Humans; Hypergammaglobulinemia; Leishmania donovani; Leishmaniasis, Visceral; Leukopenia; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pakistan; Splenomegaly; Thrombocytopenia; Weight Loss | 1998 |
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
Topics: Aminopeptidases; Animals; Diabetes Mellitus, Experimental; Disulfides; Drug Synergism; Indoles; Male; Meglumine; Naloxone; Naltrexone; Neprilysin; Pain; Pain Measurement; Phenylalanine; Pressure; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Time Factors; Vocalization, Animal; Weight Loss | 2001 |